23 Jul, 2026
The global mammography market size reached USD 2.81 billion in 2025 and is anticipated to grow from USD 3.09 billion in 2026 to USD 6.67 billion by 2034, expanding at a CAGR of 10.1% over the forecast period from 2026 to 2034.
Mammography is the most efficient imaging technique for the early detection of breast cancer, which is the only breast imaging technique that has consistently been found to lower breast cancer-related mortality. The craniocaudal and mediolateral oblique projections depict the breast from a superior to inferior perspective, the two views of each breast displayed on screening mammograms. By making it possible for medical professionals to focus on an anomaly in a particular quadrant of the breast, using two views increases the sensitivity of mammography. The demand for mammography equipment is rising due to rising breast cancer cases and advanced knowledge of the early-stage diagnosis.
By offering free or inexpensive screening and treatment assistance, numerous governments worldwide are attempting to reduce the rise in the mortality rate due to breast cancer. For instance, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is run by the Centers for Disease Control and Prevention (C.D.C.) of the United States to give women from low-income groups access to breast and cervical cancer screening and diagnostic services. In addition, WHO has announced a global policy to reduce the mortality rate from breast cancer by 2.5% by 2040. The World Health Organization focuses on advising governments worldwide to improve screening and treatment systems to lower the mortality rate. Additionally, India's central and state governments are running health awareness programs to raise breast cancer awareness and help women with screening and treatment procedures.
The market is anticipated to experience exponential growth due to technological advancements in mammography, increasing screening efficiency, and lowering screening costs. Substantial progress has been made with the innovation of 3D mammography systems, which can detect 20% to 65% more cancer cases than 2D mammograms. Additionally, AI is improving mammography equipment to provide more accurate imaging to detect breast cancer in its earliest stages. With improved sensitivity, quicker image processing, and better breast density readings, the innovations have given the newer machines several advantages over the older ones.
North America is the most significant shareholder in the global mammography market and is expected to grow at a CAGR of 9.3% during the forecast period. Breast cancer risk is higher for women in North America due to an unhealthy lifestyle, poor diet, long work hours, alcohol use, and obesity. The second most common cancer in the USA, where 264,000 breast cancer cases are diagnosed in women yearly, is expected to increase over the next few years. To improve the detection rate at a low cost, several mammography product manufacturers are also making significant investments in the research and development of their mammograms. Thus, more screenings and diagnoses have been provided due to increased awareness and higher literacy rates among women in the area, which has helped the region's mammography market grow.
Europe is expected to grow at a CAGR of 9.8%, generating USD 1.28 billion during the forecast period. The region's mammography market is increasing due to rising government initiatives to prevent breast cancer by using mammography technology for early detection. In Europe, the geriatric population is experiencing a higher increase in breast cancer cases than the younger population, which raises the possibility of a high mortality rate from other old age-related complications. Government financing for lowering breast cancer mortality rates has grown, speeding up the use of mammography technology in the region.
sales@straitsresearch.com